# Blueprint Genetics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/blueprint-genetics

- Industry: Biotechnology
- Headquarters: Espoo, Finland
- Website: www.blueprintgenetics.com
- Total disclosed funding: $20M
- Latest round: Series A (Jul 11, 2017)
- Investors on record: 7

## About

Blueprint Genetics Oy is a genetic testing company that specializes in advanced diagnostics, offering comprehensive genetic testing solutions across multiple medical specialties to enhance patient care and clinical decision-making.Blueprint Genetics Oy, founded in 2012 and headquartered in Espoo, Finland, focuses on providing advanced genetic testing solutions. In January 2020, Quest Diagnostics acquired Blueprint Genetics, enhancing its operations in the genetic testing market. The company has been involved in a total of 4 deals, with its most recent funding round being a Series A round, raising EUR 14.00 mn from investors including Creathor Ventures, Inventure, MTIP, Pontos Group, and Stanford University, bringing the total amount raised to EUR 14.00 mn.Blueprint Genetics specializes in advanced genetic testing and diagnostics, offering a comprehensive portfolio that includes Whole Exome Sequencing, variant-specific testing, and customizable diagnostic panels across 14 medical specialties. Their services cater to healthcare providers and research institutions, enhancing patient outcomes through accurate genetic diagnoses. Their tests are utilized in various fields such as cardiology, neurology, and metabolic disorders, ensuring a broad reach for their innovative genetic solutions across North America and Europe.In the most recent year, 2023, Blueprint Genetics generated revenue of EUR 29,379,566.50, with an EBITDA of EUR 1,281,881.70. Revenue is derived from service agreements for genetic testing, focusing on specific products like Whole Exome Sequencing and tailored diagnostic panels, fostering ongoing relationships with healthcare institutions.Following the acquisition by Quest Diagnostics in January 2020, Blueprint Genetics aims to expand its product offerings and enter new markets. The company plans to introduce new testing products in the coming years and expand its presence in North America and Europe. The recent Series A funding will support these initiatives, allowing Blueprint Genetics to enhance their technological capabilities and reach broader patient populations.

## Funding rounds

- Series A, Jul 11, 2017, $16M — Inventure, Creathor Ventures, Pontos Group, Stanford University, MTIP
- Seed, Aug 29, 2014, $3.9M — Inventure, Tekes Venture Capital, Avohoidon Tutkimussäätiö

## Investors

- Inventure (https://capitalatlas.ai/funds/inventure) — Seed, Series A
- Tekes Venture Capital — Seed
- Avohoidon Tutkimussäätiö — Seed
- Creathor Ventures (https://capitalatlas.ai/funds/creathor-ventures) — Series A
- Pontos Group — Series A
- Stanford University — Series A
- MTIP (https://capitalatlas.ai/funds/mtip) — Series A